Lobomycosis Successfully Treated with Posaconazole

Beatriz Bustamante Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru; Instituto de Medicina Tropical Alexander von Humbold, Universidad Peruana Cayetano Heredia, Lima, Peru

Search for other papers by Beatriz Bustamante in
Current site
Google Scholar
PubMed
Close
,
Carlos Seas Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru; Instituto de Medicina Tropical Alexander von Humbold, Universidad Peruana Cayetano Heredia, Lima, Peru

Search for other papers by Carlos Seas in
Current site
Google Scholar
PubMed
Close
,
Martín Salomon Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru; Instituto de Medicina Tropical Alexander von Humbold, Universidad Peruana Cayetano Heredia, Lima, Peru

Search for other papers by Martín Salomon in
Current site
Google Scholar
PubMed
Close
, and
Francisco Bravo Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru; Instituto de Medicina Tropical Alexander von Humbold, Universidad Peruana Cayetano Heredia, Lima, Peru

Search for other papers by Francisco Bravo in
Current site
Google Scholar
PubMed
Close
Restricted access

Lobomycosis is a chronic subcutaneous mycosis for which no standard treatment is available to date. We describe a patient in Peru with lobomycosis on the left earlobe that was successfully treated with posaconazole for 27 months. No evidence of recurrence was observed after five years of follow-up.

Author Notes

* Address correspondence to Beatriz Bustamante, Av. Honorio Delgado 430, Lima 31, Peru. E-mail: ana.bustamante@upch.pe

Financial support: Beatriz Bustamante participated as study investigator in a clinical trial sponsored by Schering Plough for which the patient was enrolled. Carlos Seas was supported by an Investigator Initiated Research grant from Pfizer.

Authors' addresses: Beatriz Bustamante and Carlos Seas, Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru, and Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mails: ana.bustamante@upch.pe and carlos.seas@upch.pe. Martín Salomon, Departamento de Enfermedades Infecciosas, Tropicales y Dermatológicas, Hospital Nacional Cayetano Heredia, Lima, Peru, E-mail: martin.salomon.n@upch.pe. Francisco Bravo, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru, E-mail: fbravopuccio@gmail.com.

  • 1.

    Woods WJ, Belone A de F, Carneiro LB, Rosa PS, 2010. Ten years experience with Jorge Lobo's disease in the state of Acre, Amazon region, Brazil. Rev Inst Med Trop Sao Paulo 52: 273278.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Rodríguez-Toro G, Tellez N, 1992. Lobomycosis in Colombian Amerindian patients. Mycopathologia 120: 59.

  • 3.

    Romero RO, 1972. Jorge Lobo's disease (keloyd blastomycosis). Diagnosis of the first Peruvian case. Arch Per Pat Clin 26: 6386.

  • 4.

    Talhari S, Caparo AB, Ganter B, 1985. Jorge Lobo's disease. Second Peruvian case. Med Cut ILA 13: 201204.

  • 5.

    Machado P de A, 1972. Spontaneous regression of macular lesions in Jorge Lobo's blastomycosis. Acta Amaz (Manaus) 2: 4750.

  • 6.

    Lawrence D, Ajello L, 1986. Lobomycosis in western Brazil: report of a clinical trial with ketoconazole. Am J Trop Med Hyg 35: 162166.

  • 7.

    Carneiro FP, Maia LB, Moraes MA, de Magalhães AV, Vianna LM, Zancanaro PC, Reis CM, 2009. Lobomycosis: diagnosis and management of relapsed and multifocal lesions. Diagn Microbiol Infect Dis 65: 6264.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Fischer M, Chrusciak Talhari A, Reinel D, Talhari S, 2002. Sucessful treatment with clofazimine and itraconazole in a 46-year-old patient after 32 years duration of disease. Hautarzt 53: 677681.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Miranda MF, Unger DA, Brito AC, Carneiro FA, 2011. Jorge Lobo's disease with restricted labial presentation. An Bras Dermatol 86: 373374.

  • 10.

    Baruzzi RG, Marcopito LF, Michalany NS, Livianu J, Pinto NR, 1981. Early diagnosis and prompt treatment by surgery in Jorge Lobo's disease (keloidal lastomycosis). Mycopathologia 74: 5154.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11.

    Negroni R, Tobon A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A, 2005. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47: 339346.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Raad II, Graybill JR, Bustamante AB, Cornely OA, Gaona-Flores V, Afif C, Graham DR, Greenberg RN, Hadley S, Langston A, Negroni R, Perfect JR, Pitisuttithum P, Restrepo A, Schiller G, Pedicone L, Ullmann AJ, 2006. Safety of long-term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 42: 17261734.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    Vilani-Moreno FR, Belone A de F, Rosa PS, Madeira S, Opromolla DV, 2003. Evaluation of the vital staining method for Lacazia loboi through the experimental inoculation of BALB/c mice. Med Mycol 41: 211216.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 915 845 145
Full Text Views 455 8 0
PDF Downloads 143 9 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save